This paper compared levels of thrombospondin (TSP-1), platelet factor 4 (PF4), and soluble P-selectin (sCD62P) in citrate-theophylline-adenosine dipyridamole (CTAD) platelet-free plasma (PFP) to those in PFP from blood anticoagulated with acid-citrate-dextrose (ACD), citrate, EDTA, or heparin and subjected to room temperature or 4°C processing delay of up to 24 h. The effects of thrombin stimulation of CTAD, ACD, citrate, EDTA, or heparin blood on levels of TSP-1, PF4, and sCD62P in PFP was also investigated.
Optimized plasma preparation is essential to monitor platelet-stored molecules in humans.
Mussbacher M, Schrottmaier WC, Salzmann M, Brostjan C, Schmid JA, Starlinger P, Assinger A
Purpose
Conclusion
Levels of sCD62P were not affected by anticoagulant, processing delay, or addition of thrombin but ANOVA analysis revealed significant effects of both processing delay and anticoagulant on levels of PF4 and TSP-1. Levels of PF4 and TSP-1 were comparable between CTAD and ACD PFP and only increased non-significantly with processing delays at either temperature. In contrast, citrate PFP levels of PF4 and TSP-1 were non-significantly higher than in CTAD PFP and levels of PF4 and TSP-1 increased steadily with processing delay, but only the change in PF4 reached significance by 24 h. EDTA and heparin PFP had significantly higher PF4 and/or TSP1 than CTAD PFP when subjected to a 30 min processing delay and levels of PF4 and TSP-1 increased continuously with increasing processing delay. Addition of thrombin to the blood generally increased levels of PF4 and TSP-1 non-significantly; however, significant increases in PF4 and TSP-1 were found with thrombin in EDTA PFP after a 0.5 h processing delay and significant increases in PF4 were found in citrate PFP after a 6 h.
Studies (1)
Purpose
This study compared levels of TSP-1, PF4, and sCD62P in CTAD PFP to those in PFP from blood anticoagulated with ACD, citrate, EDTA, or heparin and subjected to room temperature or 4°C processing delay of up to 24 h. The effects of thrombin stimulation of CTAD, ACD, citrate, EDTA, or heparin blood on levels of TSP-1, PF4, and sCD62P in PFP was also investigated. Blood was collected using a 24-gauge needle from the antecubital vein of 8 healthy volunteers (5 males, 3 female) into pre-chilled and room temperature CTAD, ACD, 3.8% citrate, EDTA, and sodium heparin tubes. Blood was stored at room temperature or 4°C for 0.5, 2, 6, and 24 h before plasma isolation. Plasma was obtained by centrifugation at 1,000 x g at 4°C for 10 minutes followed by recentrifugation of the supernatant at 10,000 x g for 10 min. The resultant PFP was frozen at -80°C until analysis. To determine the effects of platelet activation, thrombin was added to blood within 30 min of collection in CTAD, ACD, citrate, EDTA, and heparin tubes and PFP was isolated after 0.5 or 6 h at 4°C or room temperature. Levels of TSP-1, PF4, and sCD62P were quantified using ELISA and compared to those in CTAD PFP processed after 30 min at 4°C.
Summary of Findings
Levels of sCD62P were not affected by anticoagulant, processing delay, or addition of thrombin. ANOVA found significant effects of both processing delay and anticoagulant on levels of PF4 and TSP-1 (P<0.0001, all). Levels of PF4 and TSP-1 were comparable between CTAD, ACD, and citrate PFP subjected to a 30 min processing delay at 4°C, but EDTA PFP had significantly higher PF4 (P<0.01) and heparin PFP had significantly higher PF4 (P<0.05) and TSP-1 (P<0.01) compared to CTAD PFP. When processed after 30 min at room temperature, PF4 and TSP-1 levels were comparable to CTAD PFP in ACD PFP, slightly but not significantly higher in citrate and heparin PFP, and significantly higher in EDTA PFP (P<0.001, both). Levels of PF4 and TSP-1 increased continuously with processing delay at either temperature in heparin and EDTA PFP with significant effects dependent on the analyte and delay. Similarly, levels of PF4 and TSP-1 increased steadily in citrate PFP, but the increase in PF4 was only significant when stored at 4°C for 24h (P<0.01). In contrast, PF4 and TSP-1 in CTAD and ACD PFP remained relatively constant with only non-significant increases observed. When analyzed as fold-increase relative to CTAD PFP processed after 30 min at 4°C, significant differences with storage were not found for ACD PFP, but citrate, heparin, and EDTA PFP had significantly higher levels of PF4 and/or TSP-1 depending on the processing delay. Addition of thrombin to the blood generally increased levels of PF4 and TSP-1 non-significantly; however, significant increases in PF4 and TSP-1 were found with thrombin stimulation of blood in EDTA PFP after a 0.5 h (P<0.0001 and P<0.01, respectively) or 6 h processing delay (P<0.0001 and P<0.05, respectively) and a significant increase in PF4 was found in citrate PFP with thrombin stimulation only after a 6 h processing delay (P<0.05).
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
NormalPlatforms
ProteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Acid-citrate-dextroseCitrateCitrate-theophylline-adenosine-dipyridamoleEDTASodium heparinBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Storage conditions With thrombinWithout thrombinStorage Storage duration 0.5 h2 h24 h6 hStorage Storage temperature 4°CRoom temperatureELISA Specific Targeted peptide/protein PF4TSP-1sCD62P